Twist Bioscience (TWST) Asset Writedowns and Impairment (2019 - 2024)
Twist Bioscience (TWST) reported Asset Writedowns and Impairment of $293000.0 for Q3 2024, down 80.89% year-over-year from $1.5 million in Q4 2023, and up 103.47% quarter-over-quarter from $144000.0 in Q2 2024.
Twist Bioscience (TWST) Asset Writedowns and Impairment (2019 - 2024) Analysis & Trends
Twist Bioscience (TWST) has 6 years of Asset Writedowns and Impairment data on file, last reported at $293000.0 in Q3 2024.
- Asset Writedowns and Impairment for Q3 2024 came in at $293000.0, down 80.89% year-over-year; the trailing twelve-month figure through Sep 2024 was $940000.0 (down 63.47% YoY), and the FY2025 annual result was -$20000.0, down 102.13% from the prior year.
- Asset Writedowns and Impairment advanced to $293000.0 in Q3 2024 per TWST's latest filing, from $144000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $17.5 million in Q3 2022 and troughed at -$1.0 million in Q2 2020.
- A 5-year average of $1.3 million and a median of $332000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment surged 1379.41% in 2022, then tumbled 91.26% in 2023.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $248000.0 in 2020, then soared by 373.39% to $1.2 million in 2021, then tumbled by 78.36% to $254000.0 in 2022, then fell by 2.36% to $248000.0 in 2023, then climbed by 18.15% to $293000.0 in 2024.
- Business Quant data shows TWST's Asset Writedowns and Impairment at $293000.0 in Q3 2024, $144000.0 in Q2 2024, and $255000.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | Twist Bioscience | 4.30 Bn | 4.30 Bn | 57.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 293,000.00 |
| Sep 30, 2024 | 293,000.00 |
| Jun 30, 2024 | 144,000.00 |
| Jun 30, 2024 | 144,000.00 |
| Mar 31, 2024 | 255,000.00 |
| Mar 31, 2024 | 255,000.00 |
| Dec 31, 2023 | 248,000.00 |
| Dec 31, 2023 | 248,000.00 |
| Sep 30, 2023 | 1.53 Mn |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 454,000.00 |
| Jun 30, 2023 | 454,000.00 |
| Mar 31, 2023 | 332,000.00 |
| Mar 31, 2023 | 332,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Sep 30, 2022 | 17.53 Mn |
| Sep 30, 2022 | 17.53 Mn |
| Jun 30, 2022 | 985,000.00 |
| Jun 30, 2022 | 985,000.00 |